Literature DB >> 7923630

Increased glomerular capillary pressure alters glomerular cytokine expression.

S J Shankland1, H Ly, K Thai, J W Scholey.   

Abstract

Increased glomerular capillary hydrostatic pressure (PGC) is an important hemodynamic determinant of glomerular injury, but the molecular events responsible for this association are poorly understood. PGC is normal in spontaneously hypertensive rats (SHR), but uninephrectomy leads to an increase in PGC and accelerated glomerulosclerosis. Since recent studies have implicated transforming growth factor-beta 1 (TGF-beta 1) and platelet-derived growth factor sought to determine if uninephrectomy increased mRNA levels for TGF-beta 1 and PDGF in glomeruli of SHR. Since treatment with the angiotensin-converting enzyme (ACE) inhibitor enalapril lowers PGC and prevents glomerulosclerosis in uninephrectomized SHR, we also sought to determine if ACE inhibitor lowered mRNA levels for TGF-beta 1 and PDGF in the glomeruli of uninephrectomized SHR. PGC increased from 53 +/- 1 to 64 +/- 1 mm Hg 1 week after uninephrectomy in SHR (P < .05). The increase in PGC was associated with a sixfold rise in mRNA levels for TGF-beta 1 and a twofold rise in mRNA levels for PDGF in glomeruli. mRNA levels for PDGF returned to normal 2 weeks after nephrectomy, but the increase in mRNA levels for TGF-beta 1 was sustained. An increase in TGF-beta 1 immunostaining was detectable in glomeruli 4 weeks after nephrectomy. Treatment with ACE inhibitor normalized PGC (51 +/- 1 mm Hg) and prevented the rise in glomerular mRNA levels for TGF-beta 1 and PDGF. We conclude that an acute increase in PGC leads to increased TGF-beta 1 and PDGF expression in the glomerulus, thus linking changes in PGC to cytokine gene expression.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7923630     DOI: 10.1161/01.res.75.5.844

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  8 in total

1.  Spontaneously reduced blood pressure load in the rat streptozotocin-induced diabetes model: potential pathogenetic relevance.

Authors:  Anil K Bidani; Maria Picken; Rifat Hacioglu; Geoffrey Williamson; Karen A Griffin
Journal:  Am J Physiol Renal Physiol       Date:  2006-09-12

2.  Artemisinin analogue SM934 ameliorates the proteinuria and renal fibrosis in rat experimental membranous nephropathy.

Authors:  Tian-tian Li; Xiao-hui Zhang; Jing-feng Jing; Xin Li; Xiao-qian Yang; Feng-hua Zhu; Wei Tang; Jian-ping Zuo
Journal:  Acta Pharmacol Sin       Date:  2015-01-26       Impact factor: 6.150

3.  Increased expression of transforming growth factor-beta1 during gastric ulcer healing in rats.

Authors:  K Tominaga; T Arakawa; S Kim; H Iwao; K Kobayashi
Journal:  Dig Dis Sci       Date:  1997-03       Impact factor: 3.199

4.  Protection of Renal Function with ACE Inhibitors: Experience with Benazepril.

Authors:  J C Aldigier; Y L Meur; P Brunel
Journal:  Clin Drug Investig       Date:  1998       Impact factor: 2.859

5.  Role of endogenous CYP450 metabolites of arachidonic acid in maintaining the glomerular protein permeability barrier.

Authors:  Jan Michael Williams; Mukut Sharma; Siddam Anjaiahh; John R Falck; Richard J Roman
Journal:  Am J Physiol Renal Physiol       Date:  2007-05-16

6.  Follow-up after neonatal heart disease repair: watch out for chronic kidney disease and hypertension!

Authors:  Louis Huynh; Sara Rodriguez-Lopez; Kelly Benisty; Adrian Dancea; Daniel Garros; Erin Hessey; Ari Joffe; Rachel Joffe; Andrew Mackie; Ana Palijan; Alex Paun; Michael Pizzi; Michael Zappitelli; Catherine Morgan
Journal:  Pediatr Nephrol       Date:  2020-06-04       Impact factor: 3.714

Review 7.  Chronic kidney disease in congenital heart disease patients: a narrative review of evidence.

Authors:  Catherine Morgan; Mohammed Al-Aklabi; Gonzalo Garcia Guerra
Journal:  Can J Kidney Health Dis       Date:  2015-08-11

Review 8.  A compendium of urinary biomarkers indicative of glomerular podocytopathy.

Authors:  Miroslav Sekulic; Simona Pichler Sekulic
Journal:  Patholog Res Int       Date:  2013-11-13
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.